Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dalteparin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03297359
What this trial is testing

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Who this might be right for
CancerVenous ThromboembolismObesity
Ottawa Hospital Research Institute 92
Not applicableLooking for participantsNCT07302620
What this trial is testing

HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT

Who this might be right for
Thromboembolic Disease
University Hospital, Strasbourg, France 70
Large-scale testing (Phase 3)Study completedNCT00225108
What this trial is testing

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Who this might be right for
Deep Vein Thrombosis
Ottawa Hospital Research Institute 30
Not applicableUnknownNCT01029821
What this trial is testing

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

Who this might be right for
Deep Venous Thrombosis
University of Tennessee 100
Not applicableStudy completedNCT03218514
What this trial is testing

Venous Thromboprophylaxis in Bariatric Surgery

Who this might be right for
Obesity
Groupe Hospitalier Pitie-Salpetriere 118
Not applicableStudy completedNCT01721928
What this trial is testing

Norwegian Intensive Care Unit Dalteparin Effect Study

Who this might be right for
Acute Kidney InjuryDeep Venous Thrombosis
Oslo University Hospital 70
Post-approval studies (Phase 4)Study completedNCT00965328
What this trial is testing

Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration

Who this might be right for
KidneyAcute Renal FailureMultiple Organ Failure
Onze Lieve Vrouwe Gasthuis 14
Large-scale testing (Phase 3)Study completedNCT02073682
What this trial is testing

Cancer Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more
Daiichi Sankyo 1,046
Post-approval studies (Phase 4)Study completedNCT00203580
What this trial is testing

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Who this might be right for
ThrombosisThromboembolismVenous Thrombosis
University of Calgary 910
Not applicableUnknownNCT05279391
What this trial is testing

Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19

Who this might be right for
COVID-19 Severe Respiratory Failure
Democritus University of Thrace 150
Large-scale testing (Phase 3)Study completedNCT04569279
What this trial is testing

Rivaroxaban vs. Warfarin in CVT Treatment

Who this might be right for
Cerebral Vein Thrombosis
Damascus University 71
Large-scale testing (Phase 3)Study completedNCT00312013
What this trial is testing

Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 503
Not applicableStudy completedNCT01064596
What this trial is testing

Fondaparinux Population Pharmacokinetic to Morbid Obese Patients in Post-operatory Bariatric Surgery

Who this might be right for
Morbid ObesityObesitySurgery
Centre Hospitalier Universitaire de Saint Etienne 40
Post-approval studies (Phase 4)Study completedNCT05672550
What this trial is testing

Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX)

Who this might be right for
Pediatric Kidney Transplant Recipients
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Ended earlyNCT02749617
What this trial is testing

A Pilot Study Investigating Apixaban and Dexamethasone InterAction in Multiple Myeloma

Who this might be right for
Anti-Xa Activity
University of British Columbia 2
Testing effectiveness (Phase 2)Study completedNCT02981472
What this trial is testing

The Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Who this might be right for
Thrombosis
Bristol-Myers Squibb 192
Not applicableUnknownNCT02375646
What this trial is testing

Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients

Who this might be right for
Post Polypectomy Bleeding in Anticoagulated PatientsGastrointestinal Hemorrhage
Hadassah Medical Organization 286
Not applicableNot Yet RecruitingNCT07365670
What this trial is testing

Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Intensive Care (COMPAXE-HNF)

Who this might be right for
Congenital Heart DiseaseUnfractionated HeparinAnti Xa Activity
Centre Hospitalier Universitaire de la Réunion 22
Not applicableUnknownNCT00669721
What this trial is testing

OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis

Who this might be right for
Renal FailureHemodialysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 40
Post-approval studies (Phase 4)Study completedNCT02326051
What this trial is testing

Timing of Initiation of LMWH Administration in Pregnant Women With APS

Who this might be right for
Recurrent MiscarriageAntiphospholipid Syndrome
Mohamed Sayed Abdelhafez 100
Next Page